222 related articles for article (PubMed ID: 12719721)
1. Mouse models with modified p53 sequences to study cancer and ageing.
Clarke AR; Hollstein M
Cell Death Differ; 2003 Apr; 10(4):443-50. PubMed ID: 12719721
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of p53 mutant mice.
Dumble ML; Donehower LA; Lu X
Methods Mol Biol; 2003; 234():29-49. PubMed ID: 12824523
[TBL] [Abstract][Full Text] [Related]
3. Insights into aging obtained from p53 mutant mouse models.
Dumble M; Gatza C; Tyner S; Venkatachalam S; Donehower LA
Ann N Y Acad Sci; 2004 Jun; 1019():171-7. PubMed ID: 15247009
[TBL] [Abstract][Full Text] [Related]
4. Complicating the role of p53 in aging.
Gentry A; Venkatachalam S
Aging Cell; 2005 Jun; 4(3):157-60. PubMed ID: 15924572
[TBL] [Abstract][Full Text] [Related]
5. p53 alterations in human cancer: more questions than answers.
Soussi T
Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
[TBL] [Abstract][Full Text] [Related]
6. The p53-deficient mouse: a model for basic and applied cancer studies.
Donehower LA
Semin Cancer Biol; 1996 Oct; 7(5):269-78. PubMed ID: 9110404
[TBL] [Abstract][Full Text] [Related]
7. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
Soussi T; Hjortsberg L
Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
[TBL] [Abstract][Full Text] [Related]
8. Probing p53 biological functions through the use of genetically engineered mouse models.
Attardi LD; Donehower LA
Mutat Res; 2005 Aug; 576(1-2):4-21. PubMed ID: 16038709
[TBL] [Abstract][Full Text] [Related]
9. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
10. Anti-aging activity of the Ink4/Arf locus.
Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
[TBL] [Abstract][Full Text] [Related]
11. Delayed ageing through damage protection by the Arf/p53 pathway.
Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the p53 pathway.
Pietsch EC; Humbey O; Murphy ME
Oncogene; 2006 Mar; 25(11):1602-11. PubMed ID: 16550160
[TBL] [Abstract][Full Text] [Related]
13. Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.
Wesierska-Gadek J; Ranftler C; Schmid G
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():77-88. PubMed ID: 16077192
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility?
Coates PJ; Lorimore SA; Lindsay KJ; Wright EG
J Pathol; 2003 Nov; 201(3):377-88. PubMed ID: 14595749
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
16. Aging, p53 and the '24 gene mutant': getting it right. A reply to Vijg and Hasty.
Venkatachalam S
Aging Cell; 2005 Dec; 4(6):335-8. PubMed ID: 16300487
[No Abstract] [Full Text] [Related]
17. p53 mutant mice that display early ageing-associated phenotypes.
Tyner SD; Venkatachalam S; Choi J; Jones S; Ghebranious N; Igelmann H; Lu X; Soron G; Cooper B; Brayton C; Park SH; Thompson T; Karsenty G; Bradley A; Donehower LA
Nature; 2002 Jan; 415(6867):45-53. PubMed ID: 11780111
[TBL] [Abstract][Full Text] [Related]
18. Aging and cancer cell biology, 2008.
Campisi J
Aging Cell; 2008 Jun; 7(3):281-4. PubMed ID: 18331618
[TBL] [Abstract][Full Text] [Related]
19. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
[TBL] [Abstract][Full Text] [Related]
20. Age activator.
Novak K
Nat Rev Cancer; 2002 Feb; 2(2):81. PubMed ID: 12635170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
